US Market Report for Blood Glucose Meters 2017 - MedCore
The U.S. blood glucose meter market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose meter market was the personal segment. Personal blood glucose meters are used by individuals who manage their diabetes outside of the professional setting and monitor their blood glucose levels as a part of daily care. As the prevalence of diabetes in the U.S. increases, it is expected that the personal segment will continue to account for the majority of the total blood glucose meter market. Professional meters are used by clinicians and staff in the hospital or long term care settings to measure the blood glucose levels of their diabetic patients. Meters in the hospital are typically more technologically advanced than meters found in other settings and often involve software systems which analyze data and provide higher accuracy than personal meters. The growing number of individuals living in nursing homes or other long term care facilities who have diabetes will be the primary driver of market growth. However, as assisted living is becoming more popular, patients are opting for their own personal meters. Long term care centers are also starting to enforce ‘one patient-one meter’ policies, shifting the focus away from professional meters.
Blood glucose meters are electronic devices that analyze a small drop of blood drawn using a lancet and lancing device. The blood is placed on a small disposable test strip that is inserted into the blood glucose meter, which reads the level of glucose in the blood. The blood glucose meter is battery-powered and fits in the palm of the hand. When the blood is placed on the strip, it flows in through capillary action. The electrochemical reaction between the test strip and the blood determines the blood glucose concentration reported as milligrams per deciliter (mg/dL) or millimoles per liter (mmol/L).